ΣΧΕΤΙΚΑ ΜΕ ΤΟ NEUROASPIS
ΚΛΙΝΙΚΕΣ ΜΕΛΕΤΕΣA novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial >>
ΔΗΜΟΣΙΕΥΣΕΙΣΠάνω από 45 Supportive Statements και Δημοσιεύσεις σχετικά με το NEUROASPIS από το 1997 >>
Neuroaspis was presented at DGN Congress during Neurowoche 2018, 30/10-3/11 in Berlin. DGN Congress is one of the largest German-speaking medical congresses and one of the three most visited neurological congresses worldwide. https://www.dgn.org/rubrik-dgn/der-dgn-kongress
NEUROASPIS® was presented at ECTRIMS Berlin 2018, the 34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis, which was held between 10-12 October in Berlin. ECTRIMS is the world’s largest annual international conference devoted to basic and clinical research in Multiple Sclerosis.